ERBB3 and melanoma: Notably, a meta-analysis of 12 studies found that elevated ErbB3 protein expression was associated with worse overall survival not only in BRCA patients, but also in patients with colorectal, gastric, melanoma, ovarian, head and neck, pancreatic, and cervical cancers (Ocana et al., 2013).